These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12459423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
    Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL.
    J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
    [Abstract] [Full Text] [Related]

  • 4. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
    Torzewski M, Shaw PX, Han KR, Shortal B, Lackner KJ, Witztum JL, Palinski W, Tsimikas S.
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2307-12. PubMed ID: 15528482
    [Abstract] [Full Text] [Related]

  • 5. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
    Tsimikas S, Shortal BP, Witztum JL, Palinski W.
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
    Shaw PX, Hörkkö S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, Chen PP, Witztum JL.
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein.
    O'Brien KD, Alpers CE, Hokanson JE, Wang S, Chait A.
    Circulation; 1996 Sep 15; 94(6):1216-25. PubMed ID: 8822972
    [Abstract] [Full Text] [Related]

  • 11. Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia.
    Bozóky Z, Balogh L, Máthé D, Fülöp L, Bertók L, Jánoki GA.
    Eur Biophys J; 2004 Apr 15; 33(2):140-5. PubMed ID: 14663630
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y, Li Q, Rosario R, Sedlar M, Majewski S, Hudson BI, Einstein AJ, Schmidt AM, Johnson LL.
    Circ Cardiovasc Imaging; 2008 Nov 15; 1(3):212-9. PubMed ID: 19808545
    [Abstract] [Full Text] [Related]

  • 16. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis.
    Tsai WC, Li YH, Chao TH, Chen JH.
    J Formos Med Assoc; 2002 Oct 15; 101(10):681-4. PubMed ID: 12517040
    [Abstract] [Full Text] [Related]

  • 17. Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque.
    Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Takai N, Kamihashi J, Shiomi M, Minami M, Kita T, Saji H.
    J Nucl Med; 2008 Oct 15; 49(10):1677-85. PubMed ID: 18794262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy<sup/>.
    Hartley A, Haskard D, Khamis R.
    Trends Cardiovasc Med; 2019 Jan 15; 29(1):22-26. PubMed ID: 29934015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.